肌缩侧面硬化症 (ALS) 第8类型:叙述性综述
Billy McBenedict1, Wilhelmina N Hauwanga2, Uzma Nezam1
1Neurosurgery, Fluminense Federal University, Niterói, BRA.
Cureus
|February 3, 2025
概括
肌缩侧面硬化8型 (ALS8) 是一种罕见的遗传ALS亚型,由VAPB基因突变引起. 目前的治疗方法提供了有限的益处,需要对新型基因疗法和亚型特定干预措施进行研究,以改善患者护理.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 肌缩侧面硬化8型 (ALS8) 是一种罕见的家族亚型的ALS.
- 它是由囊泡相关膜蛋白相关蛋白B (VAPB) 基因的突变引起的,特别是p.P56S突变.
- ALS8呈现出明显的特征:进展缓慢,早期发病,严重的,,震和认知/行为问题.
研究的目的:
- 审查目前针对ALS的治疗策略8.
- 讨论治疗这种罕见的ALS亚型的独特临床轨迹和挑战.
- 探索创新的潜在途径,特定于亚型的干预措施.
主要方法:
- 这项研究是一篇叙事性综述.
- 它综合了有关ALS8遗传学,临床特征和治疗方法的现有文献.
- 专注于ALS8治疗的挑战和未来方向.
主要成果:
- 目前的药理治疗方法 (如瑞卢,埃达拉等) 提供适度的好处,不针对遗传原因.
- 像基因疗法和基于RNA的干预等新兴疗法显示出有前途,但面临临临床障碍.
- 症状管理 (呼吸,营养,心理) 对于患者的生活质量至关重要.
结论:
- 由于ALS8的罕见性,可变的表现和有限的数据挑战了治疗的发展.
- 多学科和有针对性的方法对于优化护理至关重要.
- 对特定亚型干预措施的进一步研究对于推进ALS8治疗至关重要.
相关概念视频
Parkinson's Disease: Overview
447
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
447
Cross-bridge Cycle
116.6K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
116.6K
Myasthenia Gravis: Overview and Treatment
1.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.1K
Amyloid Fibrils
9.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.2K
Lysosomal Hydrolases
3.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.7K
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K


